Basic Information
GlycoDesign is a developer of patented drugs for the treatment or prevention of cardiovascular and chronic inflammatory diseases, as well as cancer. The company focuses on the development of two antithrombotic drug candidates, GH9001 and ATH, as well as glycotherapeutic drugs for the treatment of chronic inflammation and cancer.
GlycoDesign
Toronto,Ontario,Canada
unclear
January 01, 1993
--
--